LONDON, May 3, 2018 /PRNewswire/ --
(Logo: Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
Report Details
The generic drugs market is estimated at $257.3bn in 2017 and is expected to grow at a CAGR of 7.9% from 2017 to 2028. The generic drugs market is expected to grow at a CAGR of 7.2% in the second half of the forecast period.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 254-page report you will receive 66 tables and 84 figures- all unavailable elsewhere.
The 254-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Generic Drugs Market forecasts from 2018-2028
• Generic Drugs Regional Market and National Market forecasts from 2018-2028, covering: • North America: US & Canada • Europe: Germany, UK, France, Italy, Spain, Rest of Europe • Asia-Pacific: Japan, Australia, India, China, South Korea, Rest of Asia-Pacific • Middle East & Africa: South Africa, Saudi Arabia, U.A.E, Rest of Middle East & Africa • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
• SWOT Analysis and Porter's Five Forces Analysis of the generic drugs market.
• Assessment of selected leading companies that hold major market shares in the generic drugs market. • Teva • Novartis (Sandoz) • Allergan • Mylan • Pfizer • Abbott • Sun Pharma • Aspen • Fresenius Kabi • Sanofi • Dr. Reddy's Laboratories • Apotex
Visiongain's study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.
Buy our report today Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on: https://www.visiongain.com/Report/2179/Generic-Drugs-Market-Forecast-2018-2028
List of Companies Mentioned in the Report
Abbott
AbbVie
Able Laboratories
Aché
Actavis
Alcon (Novartis)
Allergan (Actavis)
Amgen
Anda Inc
Apotex
APP Pharmaceuticals
Arrow Group (Actavis)
Ascent Pharmahealth (Actavis)
ASKA Pharmaceuticals
Aspen
AstraZeneca
Aurobindo
Auspex Pharmaceuticals
Bedford Laboratories
Bergamo (Amgen)
Biocon
Bioniche Pharma (Mylan)
BMP Sunstone (Sanofi)
Caraco
Celltrion
CFR Pharmaceuticals (Abbott)
Cipla
Claris
Dabur Pharma (Fresenius Kabi)
Daiichi Sankyo
Dalim BioTech
Dr Reddy's Laboratory
Ebewe Pharma (Novartis)
Eden Biopharm Group
Egis
Elder Pharmaceuticals (Torrent Pharmaceuticals)
Eli Lilly
Elyson Pharmaceuticals
EMS Sigma Pharma
Eon Labs
Eurofarma Laboratories
Farmacias Similares
Fenwal (Fresenius Kabi)
Forest Laboratories (Actavis)
Foshan Chanbende Development
Fougera Pharmaceuticals (Novartis)
Fresenius Kabi
Fresenius SE & Co
Fuji Pharma
Gavis Pharmaceuticals
Gedeon Richter
Genfar S.A (Sanofi)
Genzyme (Sanofi)
Gilead Sciences
GlaxoSmithKline (GSK)
Greenstone (Pfizer)
Grupo Sanborns
Grupo Uriach
Hexal
Hospira (Pfizer)
IDEV Technologies (Abbott)
Ilsung Pharmaceuticals
Imperial Credit Private Limited
InnoPharma Inc
Itero Biopharmaceuticals
Janssen
Javelin Pharmaceuticals (Hospira)
Johnson & Johnson
Kmart
KMS Pharmaceutical
Kowa Pharmaceuticals
Krka
Labesfal Genéricos (Fresenius Kabi)
Laboratorio Sanderson (Fresenius Kabi)
Laboratorios Best
Laboratorios Kendrick (Sanofi)
Lek (Novartis)
Lundbeck
Lupin
Matrix Laboratories
Mayne Pharma (Hospira)
Meda AB
Medley (Sanofi)
Merck KGaA
MN Pharma (Amgen)
Momenta Pharmaceuticals
Mylan
Natco Pharma
Nexus Pharmaceuticals
Nichi-Iko
Nippon Chemiphar
Novartis (Sandoz)
Novo Nordisk
OptiMedica (Abbott)
Orchid Chemicals & Pharmaceuticals
Oriel Therapeutics (Novartis)
Parenteral Drugs India Ltd
Perrigo
Pfizer
Piramal (Abbott Laboratories)
Pliva (Teva)
PT Soho Global Health
Ranbaxy (Sun Pharmaceuticals)
Ratiopharm
Rimsa
Roche
Sabex (Novartis)
Sanofi
Sawai Pharmaceuticals
Schein Pharmaceutical (Actavis)
Servier
Shelys (Aspen)
Sigma Pharmaceuticals (Aspen)
Solvay Pharmaceuticals (Abbott)
Specifar Pharmaceuticals (Actavis)
St. Jude Medical
STADA Arzneimittel
Strides Arcolab
Sun Pharma
Synthon
Taiyo Pharmaceuticals
Takeda
Teuto Brasileiro (Pfizer)
Teva
The Laboratory of Analytical Services International Ltd
Towa
UDL Laboratories
Uteron Pharma (Actavis)
Valeant Pharmaceuticals
Wal-Mart
Warner Chilcott (Actavis)
Watson
Wockhardt
Wyeth (Pfizer)
Zentiva (Sanofi)
Zhejiang Chiral Medicine Chemicals Co. Ltd
Zhejiang Hisun Pharmaceutical
Zydus Cadila
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain
Advertisement
Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico
Advertisement
(Logo: Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
Report Details
The generic drugs market is estimated at $257.3bn in 2017 and is expected to grow at a CAGR of 7.9% from 2017 to 2028. The generic drugs market is expected to grow at a CAGR of 7.2% in the second half of the forecast period.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 254-page report you will receive 66 tables and 84 figures- all unavailable elsewhere.
The 254-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Generic Drugs Market forecasts from 2018-2028
• Generic Drugs Regional Market and National Market forecasts from 2018-2028, covering: • North America: US & Canada • Europe: Germany, UK, France, Italy, Spain, Rest of Europe • Asia-Pacific: Japan, Australia, India, China, South Korea, Rest of Asia-Pacific • Middle East & Africa: South Africa, Saudi Arabia, U.A.E, Rest of Middle East & Africa • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
• SWOT Analysis and Porter's Five Forces Analysis of the generic drugs market.
• Assessment of selected leading companies that hold major market shares in the generic drugs market. • Teva • Novartis (Sandoz) • Allergan • Mylan • Pfizer • Abbott • Sun Pharma • Aspen • Fresenius Kabi • Sanofi • Dr. Reddy's Laboratories • Apotex
Visiongain's study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.
Buy our report today Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on: https://www.visiongain.com/Report/2179/Generic-Drugs-Market-Forecast-2018-2028
List of Companies Mentioned in the Report
Abbott
AbbVie
Able Laboratories
Aché
Actavis
Alcon (Novartis)
Allergan (Actavis)
Amgen
Anda Inc
Apotex
APP Pharmaceuticals
Arrow Group (Actavis)
Ascent Pharmahealth (Actavis)
ASKA Pharmaceuticals
Aspen
AstraZeneca
Aurobindo
Auspex Pharmaceuticals
Bedford Laboratories
Bergamo (Amgen)
Biocon
Bioniche Pharma (Mylan)
BMP Sunstone (Sanofi)
Caraco
Celltrion
CFR Pharmaceuticals (Abbott)
Cipla
Claris
Dabur Pharma (Fresenius Kabi)
Daiichi Sankyo
Dalim BioTech
Dr Reddy's Laboratory
Ebewe Pharma (Novartis)
Eden Biopharm Group
Egis
Elder Pharmaceuticals (Torrent Pharmaceuticals)
Eli Lilly
Elyson Pharmaceuticals
EMS Sigma Pharma
Eon Labs
Eurofarma Laboratories
Farmacias Similares
Fenwal (Fresenius Kabi)
Forest Laboratories (Actavis)
Foshan Chanbende Development
Fougera Pharmaceuticals (Novartis)
Fresenius Kabi
Fresenius SE & Co
Fuji Pharma
Gavis Pharmaceuticals
Gedeon Richter
Genfar S.A (Sanofi)
Genzyme (Sanofi)
Gilead Sciences
GlaxoSmithKline (GSK)
Greenstone (Pfizer)
Grupo Sanborns
Grupo Uriach
Hexal
Hospira (Pfizer)
IDEV Technologies (Abbott)
Ilsung Pharmaceuticals
Imperial Credit Private Limited
InnoPharma Inc
Itero Biopharmaceuticals
Janssen
Javelin Pharmaceuticals (Hospira)
Johnson & Johnson
Kmart
KMS Pharmaceutical
Kowa Pharmaceuticals
Krka
Labesfal Genéricos (Fresenius Kabi)
Laboratorio Sanderson (Fresenius Kabi)
Laboratorios Best
Laboratorios Kendrick (Sanofi)
Lek (Novartis)
Lundbeck
Lupin
Matrix Laboratories
Mayne Pharma (Hospira)
Meda AB
Medley (Sanofi)
Merck KGaA
MN Pharma (Amgen)
Momenta Pharmaceuticals
Mylan
Natco Pharma
Nexus Pharmaceuticals
Nichi-Iko
Nippon Chemiphar
Novartis (Sandoz)
Novo Nordisk
OptiMedica (Abbott)
Orchid Chemicals & Pharmaceuticals
Oriel Therapeutics (Novartis)
Parenteral Drugs India Ltd
Perrigo
Pfizer
Piramal (Abbott Laboratories)
Pliva (Teva)
PT Soho Global Health
Ranbaxy (Sun Pharmaceuticals)
Ratiopharm
Rimsa
Roche
Sabex (Novartis)
Sanofi
Sawai Pharmaceuticals
Schein Pharmaceutical (Actavis)
Servier
Shelys (Aspen)
Sigma Pharmaceuticals (Aspen)
Solvay Pharmaceuticals (Abbott)
Specifar Pharmaceuticals (Actavis)
St. Jude Medical
STADA Arzneimittel
Strides Arcolab
Sun Pharma
Synthon
Taiyo Pharmaceuticals
Takeda
Teuto Brasileiro (Pfizer)
Teva
The Laboratory of Analytical Services International Ltd
Towa
UDL Laboratories
Uteron Pharma (Actavis)
Valeant Pharmaceuticals
Wal-Mart
Warner Chilcott (Actavis)
Watson
Wockhardt
Wyeth (Pfizer)
Zentiva (Sanofi)
Zhejiang Chiral Medicine Chemicals Co. Ltd
Zhejiang Hisun Pharmaceutical
Zydus Cadila
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain
